Masashi Nakayama Selected Research

Masashi Nakayama Research Topics

Disease

31	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 11/2003
27	Neoplasms (Cancer) 12/2023 - 02/2004
17	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 06/2007
11	Neoplasm Metastasis (Metastasis) 04/2022 - 06/2007
7	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 07/2006
6	Carcinoma (Carcinomatosis) 05/2024 - 11/2003
5	Lymphatic Metastasis 09/2021 - 04/2012
4	Disease Progression 05/2024 - 09/2010
4	Atrophy 01/2023 - 09/2003
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2009 - 11/2005
3	Prostatic Intraepithelial Neoplasia 01/2023 - 09/2003
3	Anemia 01/2023 - 01/2008
3	Carcinogenesis 02/2004 - 09/2003
2	Hepatitis 01/2024 - 09/2021
2	Adenocarcinoma 01/2023 - 09/2003
2	Lung Abscess 04/2022 - 05/2014
2	Lymphoma (Lymphomas) 02/2020 - 06/2007
2	Margins of Excision 01/2017 - 04/2012
2	Testicular Neoplasms (Testicular Cancer) 05/2014 - 06/2007
2	Residual Neoplasm 09/2013 - 06/2007
2	Carcinoma in Situ 03/2010 - 04/2009
2	Seminoma 01/2010 - 11/2008
2	Kidney Neoplasms (Kidney Cancer) 04/2009 - 06/2007
2	Inflammation (Inflammations) 06/2007 - 11/2003
1	Cytokine Release Syndrome 01/2024
1	Abdominal Pain (Pain, Abdominal) 01/2024
1	Renal Insufficiency (Renal Failure) 04/2023
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 04/2023
1	Signet Ring Cell Carcinoma 04/2023
1	Pneumothorax 04/2022
1	Pleural Empyema (Pyothorax) 04/2022
1	Fistula 04/2022
1	Pneumonia (Pneumonitis) 09/2021
1	Osteonecrosis (Kienbock's Disease) 03/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2021

Drug/Important Bio-Agent (IBA)

6	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2008
6	NivolumabIBA 01/2023 - 07/2020
5	Axitinib (AG 013736)IBA 01/2024 - 10/2016
5	Hormones (Hormone)IBA 12/2023 - 06/2006
5	AndrogensIBA 12/2023 - 01/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2004
5	Prostate-Specific Antigen (Semenogelase)IBA 02/2020 - 08/2011
5	Proteins (Proteins, Gene)FDA Link 07/2015 - 09/2003
4	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 06/2007
4	Immune Checkpoint InhibitorsIBA 12/2022 - 10/2020
4	Dexamethasone (Maxidex)FDA LinkGeneric 08/2013 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 02/2004
3	NF-kappa B (NF-kB)IBA 01/2008 - 06/2006
2	avelumabIBA 05/2024 - 04/2023
2	nedaplatinIBA 04/2023 - 06/2007
2	Gemcitabine FDA Link 04/2023 - 11/2020
2	Glutathione S-Transferase piIBA 01/2023 - 09/2003
2	cabazitaxel FDA Link 01/2023 - 02/2020
2	IpilimumabIBA 10/2022 - 04/2022
2	Tyrosine Kinase InhibitorsIBA 11/2021 - 09/2021
2	Everolimus FDA Link 07/2020 - 10/2016
2	Sunitinib (Sutent)FDA Link 07/2020 - 10/2016
2	EnzymesIBA 05/2020 - 05/2007
2	Sorafenib (BAY 43-9006)FDA Link 10/2016 - 11/2012
2	InterferonsIBA 10/2016 - 02/2008
2	Estramustine FDA Link 02/2014 - 08/2013
2	Interferon-alpha (Interferon Alfa)IBA 09/2012 - 04/2009
2	Scavenger Receptors (Scavenger Receptor)IBA 06/2010 - 02/2009
2	Conditioned Culture MediaIBA 01/2010 - 06/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2009 - 01/2008
2	Messenger RNA (mRNA)IBA 04/2009 - 06/2005
2	Endothelin A ReceptorIBA 01/2008 - 06/2006
2	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2004 - 02/2004
1	PlatinumIBA 05/2024
1	pembrolizumabIBA 01/2024
1	tocilizumab (atlizumab)FDA Link 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 01/2024
1	Therapeutic UsesIBA 12/2023
1	CytosineIBA 01/2023
1	taxaneIBA 01/2023
1	GuanineIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	niraparibIBA 12/2022
1	Circulating Tumor DNAIBA 12/2022
1	ProteomeIBA 12/2022
1	Anti-Infective Agents (Microbicides)IBA 04/2022
1	Zoledronic Acid (Zometa)FDA Link 03/2021
1	Bone Density Conservation AgentsIBA 03/2021
1	Denosumab FDA Link 03/2021

Therapy/Procedure

28	Therapeutics 05/2024 - 01/2008
13	Drug Therapy (Chemotherapy) 05/2024 - 06/2007
8	Nephrectomy 01/2024 - 03/2009
8	Prostatectomy (Retropubic Prostatectomy) 01/2017 - 07/2006
6	Radiotherapy 12/2023 - 11/2009
6	Castration 01/2023 - 08/2013
3	Adjuvant Chemotherapy 11/2015 - 10/2012
2	Adrenalectomy 04/2020 - 01/2019
2	Oral Administration 02/2011 - 06/2007
2	Lasers (Laser) 05/2009 - 09/2003
2	Molecular Targeted Therapy 01/2008 - 06/2006
1	Drug Tapering 01/2024
1	Immunotherapy 04/2022
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 04/2022